Evidence map›Paper›PMID 36563057›Full record

ArticleChronic obstructive pulmonary diseases (Miami, Fla.)2023

Physical Activity and Symptom Burden in COPD: The Canadian Obstructive Lung Disease Study.

Loes Oostrik, Jean Bourbeau, Dany Doiron, Bryan Ross, Pei Zhi-Li, Shawn D Aaron, Kenneth R Chapman, Paul Hernandez, Francois Maltais, Darcy D Marciniuk and 5 more

Open access · diamondAbstract read
In one paragraph

Article in Chronic obstructive pulmonary diseases (Miami, Fla.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 12 institutions in 2 countries.

Loes OostrikPhysical Therapy Sciences, Program in Clinical Health Sciences, University Medical Center Utrecht, Utrecht University, Netherlands.
Jean BourbeauCentre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
Dany DoironCentre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
Bryan RossMontreal Chest Institute, McGill University Health Centre, Montreal, Quebec, Canada.
Pei Zhi-LiCentre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
Shawn D AaronOttawa Hospital Research Institute, Ottawa University, Ottawa, Canada.
Kenneth R ChapmanToronto General Hospital Research Institute, University of Toronto, Toronto, Canada.
Paul HernandezDivision of Respirology, Faculty of Medicine, Dalhousie University, Halifax, Canada.
Francois MaltaisInstitut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Quebec, Canada.
Darcy D MarciniukRespiratory Research Centre, University of Saskatchewan, Saskatoon, Canada.
Denis O'DonnellDivision of Respiratory and Critical Care Medicine, Queen's University, Kingston, Canada.
Wan C TanCentre for Heart Lung Innovation, University of British Columbia, St Paul's Hospital, Vancouver, Canada.
Don D SinCentre for Heart Lung Innovation, University of British Columbia, St Paul's Hospital, Vancouver, Canada.
Brandie WalkerDepartment of Medicine, University of Calgary, Alberta, Canada.
Tania Janaudis-FerreiraCentre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
McGill University Health Centre · CACentre for Advancing Health Outcomes · CADalhousie University · CAOttawa Hospital · CAQueen's University · CASt. Paul's Hospital · CAUniversité Laval · CAUniversity of British Columbia · CAUniversity of Calgary · CAUniversity of Saskatchewan · CAUniversity of Toronto · CAUtrecht University · NL

Funding

AlmirallAstraZeneca Canada LtdBoehringer Ingelheim Canada LtdCIHR 93326CRRNGlaxoSmithKline Canada LtdJo Kolk Study Fund FoundationMerckNovartisNycomedPfizer Canada LtdRespiratory Health Network of the FRSQTheratechnologies
6 · The paper itself

Abstract

Background: The relationship between symptom burden and physical activity (PA) in chronic obstructive pulmonary disease (COPD) remains poorly understood with limited data on undiagnosed individuals and those with mild to moderate disease. Objective: The primary objective was to evaluate the relationship between symptom burden and moderate-to-vigorous intensity PA (MVPA) in individuals from a random population-based sampling mirroring the population at large. Methods: Baseline participants of the Canadian Cohort Obstructive Lung Disease (n=1558) were selected for this cross-sectional sub-study. Participants with mild COPD (n=406) and moderate COPD (n=331), healthy individuals (n=347), and those at risk of developing COPD (n=474) were included. The Community Healthy Activities Model Program for Seniors (CHAMPS) questionnaire was used to estimate MVPA in terms of energy expenditure. High symptom burden was classified using the COPD Assessment Test ([CAT] ≥10). Results: Significant associations were demonstrated between high symptom burden and lower MVPA levels in the overall COPD sample (β=-717.09; 95% confidence interval [CI]=-1079.78, -354.40; Conclusion: MVPA was found to be inversely related to symptom burden in a large general population sample that included newly diagnosed individuals, most with mild to moderate COPD. Assessment of symptom burden may help identify patients with lower MVPA, especially for moderate COPD and for relatively inactive individuals with mild COPD.

Indexed as

CanCOLDcopdphysical activitysymptom burdenundiagnosed

Identifiers

PMID36563057
PMCPMC9995232
OpenAlexW4312113648

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.